Checkpoint Capital L.P. / STOK
Checkpoint Capital L.P.’s Stoke Therapeutics Inc Position
Does Checkpoint Capital L.P. own Stoke Therapeutics Inc (STOK)? Not currently — the last reported position was 212.0K shares worth $5M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q3 2025
Shares
212.0K
% of Portfolio
+1.67%
Quarters Held
4
position exited
Position History STOK
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of STOK.